Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.

Alzghari, Saeed K

Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study. [electronic resource] - Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners Oct 2018 - 494-500 p. digital

Publication Type: Comparative Study; Journal Article

1477-092X

10.1177/1078155217718382 doi


Aged
Aged, 80 and over
Anticoagulants--therapeutic use
Enoxaparin--therapeutic use
Factor Xa Inhibitors--therapeutic use
Female
Hemorrhage--chemically induced
Heparin, Low-Molecular-Weight--therapeutic use
Humans
Male
Middle Aged
Neoplasms--drug therapy
Pyrazoles--therapeutic use
Pyridones--therapeutic use
Recurrence
Retrospective Studies
Rivaroxaban--therapeutic use
Secondary Prevention
Venous Thromboembolism--drug therapy
Warfarin--therapeutic use